Authors
Evelo
- ORCiD: 0000-0002-5301-3142
- Wikidata: Q19845641
- Fatty acid biosynthesis - WP568 (Drosophila melanogaster)
- Fatty acid biosynthesis - WP504 (Rattus norvegicus)
- Fatty acid biosynthesis - WP38 (Caenorhabditis elegans)
- Fatty acid biosynthesis - WP357 (Homo sapiens)
- Fatty acid biosynthesis - WP336 (Mus musculus)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- Fatty acid beta-oxidation 1 - WP39 (Drosophila melanogaster)
- Selenium micronutrient network - WP15 (Homo sapiens)
- Fatty acid beta-oxidation - WP143 (Homo sapiens)
- Mechanisms associated with pluripotency - WP1763 (Mus musculus)
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863 (Homo sapiens)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- T-cell receptor signaling pathway - WP69 (Homo sapiens)
- TNF-related weak inducer of apoptosis (TWEAK) signaling pathway - WP2036 (Homo sapiens)
- One-carbon metabolism - WP241 (Homo sapiens)
- Spinal cord injury - WP2431 (Homo sapiens)
- Brain-derived neurotrophic factor (BDNF) signaling pathway - WP2380 (Homo sapiens)
- TNF-alpha signaling pathway - WP231 (Homo sapiens)
- RANKL/RANK signaling pathway - WP2018 (Homo sapiens)
- Melatonin metabolism and effects - WP3298 (Homo sapiens)
- SARS-CoV-2 and COVID-19 pathway - WP4846 (Homo sapiens)
- COVID-19 adverse outcome pathway - WP4891 (Homo sapiens)
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
- Spinal cord injury - WP2433 (Rattus norvegicus)
- Statin inhibition of cholesterol production - WP430 (Homo sapiens)
- Beta-oxidation of unsaturated fatty acids - WP471 (Caenorhabditis elegans)
- Oxidation by cytochrome P450 - WP43 (Homo sapiens)
- HIF1A and PPARG regulation of glycolysis - WP2456 (Homo sapiens)
- Biogenic amine synthesis - WP550 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - interferon induction - WP4880 (Homo sapiens)
- Beta-oxidation of unsaturated fatty acids - WP418 (Rattus norvegicus)
- Beta-oxidation meta-pathway - WP372 (Rattus norvegicus)
- Fatty acid beta-oxidation 3 - WP25 (Drosophila melanogaster)
- Fatty acid beta-oxidation meta-pathway - WP209 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 3 - WP499 (Caenorhabditis elegans)
- Triacylglyceride synthesis - WP212 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 2 - WP148 (Caenorhabditis elegans)
- Vitamin D metabolism - WP1531 (Homo sapiens)
- Phase I biotransformations, non P450 - WP136 (Homo sapiens)
- Fatty acid beta-oxidation 1 - WP126 (Caenorhabditis elegans)
- Exercise-induced circadian regulation - WP544 (Mus musculus)
- Triacylglyceride synthesis - WP386 (Mus musculus)
- Fatty acid omega-oxidation - WP33 (Mus musculus)
- Dopaminergic neurogenesis - WP1498 (Mus musculus)
- Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) - WP688 (Homo sapiens)
- Fatty acid omega-oxidation - WP206 (Homo sapiens)
- Nucleotide-binding oligomerization domain (NOD) pathway - WP1433 (Homo sapiens)
- IGF-1 signaling - WP2892 (Bos taurus)
- Growth hormone receptor (GHR) signaling - WP2891 (Bos taurus)
- Ketone bodies synthesis and degradation - WP311 (Homo sapiens)
- Thyroxine (thyroid hormone) production - WP1981 (Homo sapiens)
- Arachidonate epoxygenase / epoxide hydrolase - WP678 (Homo sapiens)
- Oxidative stress response - WP412 (Mus musculus)
- Proteasome degradation - WP183 (Homo sapiens)
- Fatty acid omega-oxidation - WP133 (Rattus norvegicus)
- Leptin-insulin signaling overlap - WP578 (Mus musculus)
- Spinal cord injury - WP2432 (Mus musculus)
- Insulin signaling - WP65 (Mus musculus)
- PCSK9-mediated LDL receptor degradation - WP2846 (Homo sapiens)
- Renin-angiotensin system - WP376 (Rattus norvegicus)
- Insulin signaling in adipocytes (normal condition) - WP3634 (Homo sapiens)
- Triacylglyceride synthesis - WP325 (Homo sapiens)
- One-carbon metabolism - WP435 (Mus musculus)
- Retinoblastoma gene in cancer - WP2446 (Homo sapiens)
- One-carbon metabolism and related pathways - WP1770 (Mus musculus)
- Canonical and non-canonical Notch signaling - WP3845 (Homo sapiens)
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982 (Homo sapiens)
- Type II diabetes mellitus - WP1584 (Homo sapiens)
- Amino acid conjugation - WP715 (Homo sapiens)
- Oxytocin signaling - WP2889 (Homo sapiens)
- Iron metabolism in placenta - WP2007 (Homo sapiens)
- Arylamine metabolism - WP694 (Homo sapiens)